Anaphylaxis to SARS-CoV-2 Vaccines in the Setting of a Nationwide Passive Epidemiological Surveillance Program.
Carla Toledo-SalinasSelma Cecilia Scheffler-MendozaLina Maria Castano-JaramilloJosé Antonio Ortega-MartellBlanca Estela Del Rio-NavarroAna María Santibáñez-CopadoJosé Luis Díaz-OrtegaRaúl Baptista-RosasPaulina Sánchez-NovoaMiguel García-GrimshawSergio Iván Valdés-FerrerGustavo Reyes-TeránDavid Alejandro Mendoza-HernándezPublished in: Journal of clinical immunology (2022)
In our population, anaphylactic reactions were infrequent. Our study provides further evidence supporting the security of these newly developed vaccines.